Research Chemical Designation & Liability

Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.

Full Disclaimer
Archive Identifier

Cardarine

Metabolic & Weight Loss

Molecular Dossier

  • Rank Index: 55
  • Status: Research Only
  • What does this mean?
  • Molecular Structure: MW: 453.49 g/mol | Formula: C21H18F3NO3S2 | CAS: 317318-70-0

About Cardarine

Peroxisome proliferator-activated receptor delta (PPAR-δ) agonist. Preclinical studies demonstrate dramatic improvements in endurance and fat oxidation by activating genes involved in energy expenditure. Note: Pfizer discontinued development in 2007 due to dose-dependent cancer findings in rodent studies; human safety is unestablished.

Clinical Focus

Endurance Enhancement, Fat Oxidation, PPAR-δ Activation

Archival Aliases

GW501516, GW-1516, GSK-516, Endurobol

Frequently Asked Questions

Clinical Data Matrix

Parameter Clinical Value
Molecular Weight MW: 453.49 g/mol | Formula: C21H18F3NO3S2 | CAS: 317318-70-0
Primary Pathway Metabolic & Weight Loss
Research Phase Research Only

Clinical Pros

  • Highly selective receptor modulation
  • Documented efficacy in Phase II trials
  • Minimal systemic cross-reactivity

Research Limitations

  • Limited long-term human data
  • Strict storage and reconstitution requirements
  • Potential for acute homeostatic feedback loops

Community Discussion

Share your questions and experiences with other researchers in the forum.

Discuss in Forum

Clinical Reference Nodes

[REF 1] pubmed.ncbi.nlm.nih.gov
[REF 2] pubmed.ncbi.nlm.nih.gov

Data Verified: 2026-04-14

Synergistic Matrix